| 1.8 |
7.1 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.7 |
5.2 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 1.5 |
4.6 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 1.4 |
7.1 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.3 |
6.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.3 |
5.1 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.3 |
2.5 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.2 |
3.6 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.2 |
3.5 |
GO:0002034 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 1.1 |
5.7 |
GO:0021764 |
amygdala development(GO:0021764) |
| 1.1 |
4.5 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 1.1 |
3.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 1.1 |
3.2 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.1 |
4.2 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.9 |
3.7 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.9 |
3.7 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.9 |
9.1 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.9 |
3.6 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.9 |
2.6 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.9 |
2.6 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.9 |
2.6 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.8 |
2.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.7 |
3.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.7 |
2.1 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.7 |
9.8 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.7 |
1.4 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.7 |
2.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.7 |
2.0 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.6 |
4.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.6 |
1.9 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.6 |
1.3 |
GO:0002481 |
antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.6 |
2.4 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.6 |
5.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.6 |
1.7 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.6 |
2.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.6 |
3.9 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.6 |
2.2 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 |
1.6 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.5 |
1.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.5 |
9.8 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.5 |
3.7 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.5 |
2.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.5 |
1.6 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.5 |
7.5 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.5 |
1.4 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.5 |
2.9 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.5 |
1.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.5 |
1.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 |
1.4 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 |
1.4 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 0.4 |
1.3 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.4 |
2.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.4 |
1.3 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.4 |
1.3 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
2.7 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.4 |
4.0 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.4 |
1.3 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.4 |
3.5 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.4 |
1.3 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.4 |
2.1 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.4 |
3.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 |
1.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.4 |
0.8 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.4 |
2.5 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.4 |
1.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.4 |
8.1 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.4 |
1.2 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.4 |
1.6 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 |
2.7 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.4 |
1.2 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.4 |
1.5 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.4 |
1.5 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.4 |
6.9 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.4 |
1.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.4 |
1.1 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.4 |
1.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.4 |
1.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.4 |
1.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.4 |
1.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.4 |
0.4 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.4 |
0.7 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.4 |
0.7 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.4 |
2.2 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.4 |
0.7 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.4 |
2.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.4 |
3.2 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.3 |
3.5 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 |
2.8 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.3 |
2.4 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.3 |
1.0 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
2.0 |
GO:0046060 |
ADP biosynthetic process(GO:0006172) dATP metabolic process(GO:0046060) |
| 0.3 |
0.3 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 |
1.0 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.3 |
1.6 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.3 |
5.5 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.3 |
1.0 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
1.3 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.3 |
1.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 |
0.9 |
GO:0040009 |
regulation of growth rate(GO:0040009) protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 |
0.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.3 |
0.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
1.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
1.8 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
0.9 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.3 |
2.9 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.3 |
1.1 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.3 |
0.9 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
0.8 |
GO:0003284 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) septum primum development(GO:0003284) cell communication by chemical coupling(GO:0010643) regulation of renin secretion into blood stream(GO:1900133) |
| 0.3 |
1.1 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.3 |
1.4 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 |
2.2 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.3 |
0.8 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.3 |
0.8 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
0.8 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.3 |
0.3 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.3 |
4.5 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.3 |
0.8 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) vein smooth muscle contraction(GO:0014826) |
| 0.3 |
0.3 |
GO:0032632 |
interleukin-3 production(GO:0032632) |
| 0.3 |
1.3 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.3 |
1.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 |
3.9 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.3 |
0.5 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.3 |
1.3 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.3 |
1.5 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.2 |
0.7 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
2.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
1.2 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.2 |
0.7 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
0.5 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
0.7 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.2 |
0.7 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 |
0.9 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.2 |
1.2 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.2 |
1.4 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) |
| 0.2 |
0.5 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) B cell chemotaxis(GO:0035754) |
| 0.2 |
0.7 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
1.6 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
1.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
1.6 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
1.5 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 |
0.7 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 |
1.1 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.2 |
2.0 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
1.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
3.0 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.2 |
1.3 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.2 |
0.6 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.6 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.2 |
2.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
2.5 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.2 |
0.8 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
4.0 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.2 |
1.7 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.2 |
0.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.2 |
0.6 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
1.0 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
1.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
2.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
1.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.2 |
1.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.2 |
1.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 |
0.8 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
1.6 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.2 |
0.8 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 |
1.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 |
1.0 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.2 |
2.7 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.2 |
5.7 |
GO:0007094 |
mitotic spindle assembly checkpoint(GO:0007094) |
| 0.2 |
2.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
1.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.2 |
1.5 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
0.9 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 |
0.9 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 |
1.7 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
2.2 |
GO:0050942 |
positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.2 |
1.9 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
1.1 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.2 |
0.6 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
2.4 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 |
0.5 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
1.3 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
1.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.2 |
0.5 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.2 |
0.5 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.2 |
0.9 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.2 |
0.7 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) positive regulation of integrin activation(GO:0033625) |
| 0.2 |
1.6 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.7 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 |
1.3 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
0.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
1.0 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 |
0.5 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.2 |
0.8 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
1.3 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.2 |
1.6 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
1.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
1.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 |
0.5 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.2 |
0.5 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
1.9 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
2.8 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.2 |
1.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
0.9 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.2 |
0.6 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.1 |
1.0 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.1 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.3 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.1 |
1.8 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.7 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.6 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
1.3 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.1 |
0.7 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.6 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.7 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.9 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 |
0.1 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.1 |
0.8 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.6 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
1.5 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
2.5 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.8 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
0.4 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.9 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.7 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.7 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.9 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
0.4 |
GO:1903897 |
regulation of PERK-mediated unfolded protein response(GO:1903897) |
| 0.1 |
0.9 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
1.3 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.1 |
1.2 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.8 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.5 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
2.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.4 |
GO:0010637 |
diet induced thermogenesis(GO:0002024) negative regulation of mitochondrial fusion(GO:0010637) adaptive thermogenesis(GO:1990845) |
| 0.1 |
0.3 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.1 |
0.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.7 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
1.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.7 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
1.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
1.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
2.3 |
GO:0010664 |
regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 |
0.8 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
| 0.1 |
1.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.6 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
1.5 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
0.7 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
2.0 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
0.8 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
1.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
1.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.9 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 |
0.7 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 |
0.9 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
1.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.4 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
2.0 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.4 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
1.0 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.3 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.5 |
GO:0042177 |
negative regulation of protein catabolic process(GO:0042177) |
| 0.1 |
1.0 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.5 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
0.3 |
GO:0034384 |
positive regulation of lipoprotein particle clearance(GO:0010986) high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.3 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.1 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.1 |
1.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.0 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.4 |
GO:0015868 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.1 |
1.7 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.2 |
GO:0061325 |
cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.1 |
GO:0002923 |
regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 |
0.5 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.5 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.5 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
2.4 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
0.2 |
GO:0045091 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
6.0 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
0.8 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.5 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
2.5 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.7 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.8 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.3 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
1.5 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.1 |
1.3 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
1.5 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
1.6 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.5 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.2 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
0.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
1.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.3 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.9 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
2.0 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.5 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
2.4 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
2.2 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
4.0 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.1 |
0.3 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.1 |
1.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.2 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
0.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.2 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
1.7 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.5 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
1.1 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
1.4 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.6 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.5 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.8 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
1.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 |
0.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.7 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
1.2 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
1.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
1.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
1.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
2.2 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.7 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
5.0 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.2 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 |
1.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.6 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
1.9 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
1.6 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.6 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.2 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.9 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.5 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.1 |
0.3 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.1 |
0.6 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
1.8 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
3.9 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.2 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
0.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.2 |
GO:0001991 |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
| 0.1 |
0.4 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
1.1 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
2.2 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.1 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
1.4 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.6 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 |
4.1 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
1.4 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.2 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.0 |
0.1 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) |
| 0.0 |
0.9 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.4 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
2.1 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
1.1 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.0 |
1.3 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
2.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.7 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
1.8 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.2 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
1.4 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.5 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
1.8 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.8 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.2 |
GO:0006360 |
transcription from RNA polymerase I promoter(GO:0006360) |
| 0.0 |
0.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.2 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.0 |
0.3 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.2 |
GO:0060479 |
lung epithelium development(GO:0060428) lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
1.1 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 |
1.0 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
1.7 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.3 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.0 |
1.1 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.4 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.5 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.7 |
GO:0007129 |
synapsis(GO:0007129) |
| 0.0 |
0.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.4 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.9 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.9 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.6 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.5 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
1.2 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.0 |
0.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.9 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.7 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.0 |
1.2 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
1.2 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.0 |
0.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.8 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
1.0 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.0 |
0.2 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
1.7 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.4 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.6 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.7 |
GO:0032835 |
glomerulus development(GO:0032835) |
| 0.0 |
0.8 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.2 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.0 |
0.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
1.7 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.3 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.0 |
0.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.2 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.5 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.7 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.3 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.0 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.1 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.4 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 0.0 |
0.4 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
2.5 |
GO:0043062 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.5 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.2 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.1 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.2 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.0 |
0.6 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.0 |
0.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.0 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.2 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.6 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.0 |
0.1 |
GO:0032612 |
interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
| 0.0 |
0.1 |
GO:0042073 |
intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
| 0.0 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.1 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.0 |
GO:1904729 |
regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.0 |
0.2 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.0 |
0.0 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.0 |
0.6 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.5 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.4 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
1.1 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.0 |
0.2 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.3 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 |
0.3 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) |
| 0.0 |
0.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
1.0 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.0 |
0.9 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.0 |
0.9 |
GO:0007160 |
cell-matrix adhesion(GO:0007160) |
| 0.0 |
0.3 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.1 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.0 |
GO:0060948 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) cardiac vascular smooth muscle cell differentiation(GO:0060947) cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.0 |
0.2 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
